AfoliOpen Afoli →

Aflibercept

Aflibercept is an approved active ingredient.

Open in Afoli Medicines →

Pharmaceutical drug

Informational only — not medical advice. Ask a doctor or pharmacist; never change a dose on your own.

What it is used for

ZALTRAP, in combination with fluorouracil, leucovorin, irinotecan-(FOLFIRI), is indicated for the treatment of patients with metastatic colorectal cancer (mCRC) that is resistant to or has progressed following an oxaliplatin-containing regimen.

US label

Treatment of metastatic colorectal cancer (MCRC).

EMA

How it works

Common side effects

The following clinically significant adverse reactions are described elsewhere in the labeling: Hemorrhage Gastrointestinal Perforation Impaired Wound Healing Fistula Formation Hypertension Arterial Thromboembolic Events Proteinuria Neutropenia and Neutropenic Complications Diarrhea and Dehydration Reversible…

US label

Pregnancy and breastfeeding

Based on findings from animal reproduction studies and its mechanism of action, ZALTRAP can cause fetal harm when administered to pregnant women.

Excerpts from the US prescribing label (public domain), copied without changes.

Brand names

United States

Zaltrap

European Union

Afiveg · Afqlir · Baiama · Eiyzey · Eydenzelt · Eyluxvi · Mynzepli · Vgenfli · Zaltrap

Canada

Aflivu · Eydenzelt

Approval status

US Food and Drug Administration
prescription · since 2011
European Medicines Agency
authorised · since 2012
Health Canada
prescription · marketed
First approval anywhere
2011

Codes

ATC
L01XX44, S01LA05
RxNorm CUI
1232150
ChEMBL
CHEMBL1742982
Wikidata
Q4689286

Frequently asked questions

What is Aflibercept used for?

Aflibercept is used for: Macular retinal edema, Kuhnt-Junius degeneration, Retinal vein occlusion, Colon cancer, Rectum cancer, Diabetic retinopathy, Colorectal neoplasm, and Retinal neovascularization.

What are the brand names of Aflibercept?

Brand names of Aflibercept include Zaltrap, Afiveg, Afqlir, Baiama, Eiyzey, Eydenzelt, Eyluxvi, and Mynzepli.

Medicines in the same class

Sources and licences

Updated November 15, 2026